Is Machine Learning a Better Way to Identify COVID-19 Patients Who Might Benefit from Hydroxychloroquine Treatment?—The IDENTIFY Trial

Therapeutic agents for the novel coronavirus disease 2019 (COVID-19) have been proposed, but evidence supporting their use is limited. A machine learning algorithm was developed in order to identify a subpopulation of COVID-19 patients for whom hydroxychloroquine was associated with improved surviva...

Descripción completa

Detalles Bibliográficos
Autores principales: Burdick, Hoyt, Lam, Carson, Mataraso, Samson, Siefkas, Anna, Braden, Gregory, Dellinger, R. Phillip, McCoy, Andrea, Vincent, Jean-Louis, Green-Saxena, Abigail, Barnes, Gina, Hoffman, Jana, Calvert, Jacob, Pellegrini, Emily, Das, Ritankar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760047/
https://www.ncbi.nlm.nih.gov/pubmed/33256141
http://dx.doi.org/10.3390/jcm9123834

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760047/
https://www.ncbi.nlm.nih.gov/pubmed/33256141
http://dx.doi.org/10.3390/jcm9123834

Ejemplares similares